Top Ten Topics in Clinical Cardiology

Friday, October 21, 2022, 7:00 AM - 2:35 PM, Hatch Auditorium in GP, New York, NY


As live and in-person comprehensive medical education conference, this course will offer the latest updates for diagnostic and treatment strategies that assess the risk and treatment of coronary artery disease, congestive heart failure, heart rhythm disorders, mitral valve regurgitation, aortic stenosis, and co-morbid cardiometabolic diseases. The use of case based reviews and taped case presentations will demonstrate innovative therapeutic techniques aimed at improving patient outcomes and quality of life, as well as lowering morbidity and mortality rates through the management of various conditions. A robust agenda combines individual and collective opinions from field expert clinicians and scholars.

1. Detect the role of noninvasive testing in the diagnosing of CAD and provide prognostic information.
2. Comprehend the newest innovative approaches in treatment of heart failure.
3. Recognize the recent transcatheter valve therapies with special focus on MitraClip and TAVR procedures.
4. Integrate the latest developments within interventional cardiology and their effects on improving interventional outcomes and overall patient care.

COVID-19 Safety Policy
According to institutional policy and to ensure the safety of all meeting participants, please note the following requirements:

• There will be mandatory checking of compliance with full vaccination status. You must be fully vaccinated in order to attend the activity. Boosters are strongly recommended but not required;
• Masks must be worn at all times during the event except when eating/drinking;

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, October 21, 2022